Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA-5 Follow-up: r-SAK Prior to Primary PCI in STEMI
NCT05649696Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2021
- Primary completion
- Sep 2023
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of staphylokinase in ST-segment elevation myocardial infarction (STEMI), sponsored by Jiangsu Provincial People's Hospital. Started Oct 2021; status: completed.
02
Drugs
staphylokinase
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05649696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649696.